BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30013043)

  • 1. Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1.
    Lee JH; Choi SI; Kim RK; Cho EW; Kim IG
    Sci Rep; 2018 Jul; 8(1):10711. PubMed ID: 30013043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
    Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
    Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APBB1 reinforces cancer stem cell and epithelial-to-mesenchymal transition by regulating the IGF1R signaling pathway in non-small-cell lung cancer cells.
    Lee JH; Kim JY; Kim SY; Choi SI; Kim KC; Cho EW; Kim IG
    Biochem Biophys Res Commun; 2017 Jan; 482(1):35-42. PubMed ID: 27836546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSPA1L Enhances Cancer Stem Cell-Like Properties by Activating IGF1Rβ and Regulating β-Catenin Transcription.
    Choi SI; Lee JH; Kim RK; Jung U; Kahm YJ; Cho EW; Kim IG
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
    Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
    Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and γ-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells.
    Kim IG; Lee JH; Kim SY; Hwang HM; Kim TR; Cho EW
    Cancer Sci; 2018 Nov; 109(11):3519-3531. PubMed ID: 30191639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells.
    Zeng J; Zhang H; Tan Y; Sun C; Liang Y; Yu J; Zou H
    BMC Cancer; 2018 May; 18(1):611. PubMed ID: 29848294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
    Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
    Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.
    Codony-Servat J; Codony-Servat C; Cardona AF; Giménez-Capitán A; Drozdowskyj A; Berenguer J; Bracht JWP; Ito M; Karachaliou N; Rosell R
    Clin Lung Cancer; 2019 May; 20(3):167-177. PubMed ID: 30885551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIP1 Is a Novel Component of γ-ionizing Radiation-Induced Invasion of Non-Small Cell Lung Cancer Cells.
    Kang AR; Cho JH; Lee NG; Song JY; Hwang SG; Lee DH; Um HD; Park JK
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605153
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
    Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.
    Byers LA; Sen B; Saigal B; Diao L; Wang J; Nanjundan M; Cascone T; Mills GB; Heymach JV; Johnson FM
    Clin Cancer Res; 2009 Nov; 15(22):6852-61. PubMed ID: 19861436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
    Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
    Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MerTK mediates STAT3-KRAS/SRC-signaling axis for glioma stem cell maintenance.
    Eom H; Kaushik N; Yoo KC; Shim JK; Kwon M; Choi MY; Yoon T; Kang SG; Lee SJ
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):87-95. PubMed ID: 29553850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer.
    Phan AN; Hua TN; Kim MK; Vo VT; Choi JW; Kim HW; Rho JK; Kim KW; Jeong Y
    Oncotarget; 2016 Aug; 7(34):54702-54713. PubMed ID: 27419630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
    Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
    Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
    Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.